SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-101705
Filing Date
2024-04-19
Accepted
2024-04-19 07:55:55
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-19

Document Format Files

Seq Description Document Type Size
1 ARS d796541dars.pdf ARS 2076896
  Complete submission text file 0001193125-24-101705.txt   2838232
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36167 | Film No.: 24855643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)